PPARgamma Agonists: Blood Pressure and Edema. - Wikidata - awgldk - TriplyDB

PPARgamma Agonists: Blood Pressure and Edema.

PPARgamma Agonists: Blood Pressure and Edema.

http://www.wikidata.org/entity/Q41876733

about

Systematic drug repositioning based on clinical side-effects The glucocorticoid-induced leucine zipper (gilz/Tsc22d3-2) gene locus plays a crucial role in male fertility.Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors Pseudoginsenoside F11, a Novel Partial PPAR γ Agonist, Promotes Adiponectin Oligomerization and Secretion in 3T3-L1 Adipocytes

P2860

Q28478506-5A0E3613-4F0D-4B49-BF67-D798BF8C594B Q33636398-2EE32BF4-BB4E-4B0D-AA64-45D540058550 Q33960919-748DDDB5-6BB6-43CE-8BF8-F4120D8481C4 Q37433259-52D6F4A6-3FB5-4972-A9C9-68E1327D9C05

P2860

PPARgamma Agonists: Blood Pressure and Edema.

http://www.wikidata.org/entity/Q41876733

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

PPARgamma Agonists: Blood Pressure and Edema.

@en

type

label

PPARgamma Agonists: Blood Pressure and Edema.

@en

prefLabel

PPARgamma Agonists: Blood Pressure and Edema.

@en

P1433

Q41876733-A789F92D-425A-4536-B659-21FA32886A8B

P1476

Q41876733-AF24F93D-0312-435B-9164-FA5263898807

P2093

Q41876733-DB5E187F-5233-424D-B385-326E28A0CAE4

P2860

Q41876733-0709A22E-1434-436D-B940-8EED7FFA3E80

Q41876733-16A71129-8C51-491D-8996-8E41629CE1D7

Q41876733-2B177D6F-84C1-4596-B67D-7BEA34254FAA

Q41876733-2F1AFE4E-E13E-4C8D-82A8-9425D1FDB4DD

Q41876733-302B30D8-A44F-401F-B303-AF5DB7CCDA3C

Q41876733-30E50727-E72F-49EF-B4D0-EDDEA875D640

Q41876733-3508EDE5-7DB6-4D9D-8465-21E8ABD492B1

Q41876733-37BCB96F-BE60-41D8-B60A-A9E5F654CE61

Q41876733-39D38010-3A88-4483-AA20-BCC28D7F04FE

Q41876733-3ABA1813-DD97-4C36-A6BB-9ED0E35644E7

P304

Q41876733-F63B5A39-C828-4EB7-A254-30C83BCB3CED

P31

Q41876733-866F2A04-6C8E-4262-AFC5-C0B7070D0962

P356

Q41876733-1CFF606D-C11E-45A9-83B7-874CD51C242A

P478

Q41876733-A319F7DC-EA0C-491F-95B6-99C684D524EE

P577

Q41876733-D641777A-1840-4C27-A0C8-272063AE7E61

P5875

Q41876733-62FF971F-D46F-4683-B602-B69B8AC4C376

P698

Q41876733-70FADB57-12C3-42C7-9FC9-5BEC72204D83

P932

Q41876733-7379F24B-B0D6-44DA-98A0-F1B9C5DB3113

P356

P1433

P1476

PPARgamma Agonists: Blood Pressure and Edema.

@en

P2093

Bonnie L Blazer-Yost

http://www.w3.org/2001/XMLSchema#string

P2860

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity

A common sequence variation of the CLCNKB gene strongly activates ClC-Kb chloride channel activity

'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic Studies

Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel

Mechanisms of Disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance

Activating mutation of the renal epithelial chloride channel ClC-Kb predisposing to hypertension

Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

P304

785369

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2010/785369

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41001673

http://www.w3.org/2001/XMLSchema#string

P698

20069049

http://www.w3.org/2001/XMLSchema#string

P932

2801011

http://www.w3.org/2001/XMLSchema#string